*本次說明會將於法說會前一日提供報名者線上法說會網址及登入相關密碼資訊

*The website link and login password will be provided on the day before the Conference day.

 

美時化學製藥股份有限公司 (股票代號:1795)

Lotus Pharmaceutical Co.,Ltd. (TW 1795)

法人說明會邀請函

Invitation of Investor Conference

 

Founded in 1966, Lotus now is the largest pharmaceutical company in Taiwan focusing on high-value generic products covering CNS, CVS, oncology, women health, and anti-obesity drugs in tablets & hard/softgel capsule for global markets.

By boasting a best-in-class R&D and manufacturing platform in Asia, Lotus aims to benefit patients, its employees and stakeholders alike. Furthermore, Lotus can reach nearly every global market with its high value pipeline through its direct markets and strategic alliances with top-tier pharma companies based on its industry-leading infrastructure with quality manufacturing capabilities certified by most of the advanced regulatory authorities around the world, including US FDA, EU EMA, Japan PMDA, China FDA, and Brazil ANVISA.

We would like to hold the second quarter investor conference on Aug 15, 2024 (Thur.), to provide the company’s business strategy and market update. The investor conference will be held in English.

…………………………………………………………………………………………………………..

The investor conference will be held on Aug 15, 2024(Thur.), we sincerely welcome investors to participate the conference.

 

Aug 15, 2024 (Thur.)  15:30~16:30

Webex System

Main Presenter: General Manager Petar Vazharov, Vice President Bjartur Shen

Procedure: 15:15~15:30 Webex login

   15:30~16:00 Company Operating  Description

   16:00~16:30 Q&A

 

凱基證券股份有限公司

KGI Securities

 

注意事項

1.     報名截止日期:2024813日(二),請務必於截止日前完成報名,報名完成後將於2024814()提供報名者線上法說會網址及登入相關密碼資訊

The deadline of registration: Aug 13, 2024 (Tues.). Please be sure to complete the registration before the deadline. The website link and password will be provided on Aug 14, 2024(Wed.).

2.     活動諮詢:凱基證券 鄭小姐 電話: 02-2181-8167  E-mail[email protected]

Contact Person: Janice Cheng(KGI Securities) Tel02-2181-8167  E-mail[email protected]

3.     您所填寫之相關資料,表示同意做為本公司此次邀請您參加業績發表會/法人說明會及日後本公司或發行公司寄發相關訊息使用,請詳閱以下「運用個人資料告知書」

The relevant information you have filled in means that you agree to participate the conference and KGI Securities will send relevant activities information to you in the future. Please read the following "Notice on the Use of Personal Information".